AEON Biopharma (AEON) News Today $0.82 -0.04 (-4.51%) As of 02:48 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock AEON Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2026 April 2026 March 2026 February 2026 January 2026 December 2025 November 2025 October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 Time Period AEON Biopharma Reports First Quarter 2026 Financial Results and Provides Corporate UpdateMay 14, 2026 | globenewswire.comAEON Biopharma (AEON) Projected to Post Earnings on WednesdayMay 13, 2026 | americanbankingnews.comAEON Biopharma Sets Annual Shareholder MeetingApril 24, 2026 | globenewswire.comAEON Biopharma Receives Additional NYSE American Noncompliance NoticeApril 17, 2026 | theglobeandmail.comAEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711April 3, 2026 | globenewswire.comAEON Biopharma Receives Additional Notice Related to NYSE American Continued Listing StandardsApril 3, 2026 | globenewswire.comAEON Biopharma Reports Full Year 2025 Financial Results and Highlights Positive Comparative Analytical Results and FDA Feedback for ABP-450 Biosimilar ProgramMarch 30, 2026 | globenewswire.comAeon Biopharma announces FDA feedback after Type 2a meetingMarch 27, 2026 | finance.yahoo.comAEON Biopharma Announces FDA Feedback Following BPD Type 2a Meeting for the ABP-450 Biosimilar ProgramMarch 25, 2026 | markets.businessinsider.comAEON Biopharma Inc: AEON Biopharma Appoints John Bencich as Chief Financial OfficerMarch 10, 2026 | finanznachrichten.deAeon Biopharma Appoints John Bencich as Finance ChiefMarch 10, 2026 | marketwatch.comAEON Biopharma Appoints John Bencich as Chief Financial OfficerMarch 10, 2026 | markets.businessinsider.comAEON Biopharma Abstract Accepted for Presentation at 2026 American Academy of Neurology (AAN) Annual MeetingMarch 5, 2026 | markets.businessinsider.comAEON Biopharma Inc: AEON Biopharma Reports BPD Type 2a Meeting with FDA and Shareholder Approval of the November TransactionsJanuary 22, 2026 | finanznachrichten.deAeon Biopharma stock falls after FDA meeting and debt restructuringJanuary 21, 2026 | in.investing.comAEON Biopharma Holds Meeting With FDA for Botox BiosimilarJanuary 21, 2026 | marketwatch.comAEON Biopharma Reports BPD Type 2a Meeting with FDA and Shareholder Approval of the November TransactionsJanuary 21, 2026 | globenewswire.comAEON Biopharma (AEON) price target decreased by 14.75% to 5.30January 14, 2026 | msn.comAEON Biopharma Inc: AEON Biopharma Announces Execution of Exchange Agreement with DaewoongDecember 22, 2025 | finanznachrichten.deAEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711December 19, 2025 | globenewswire.comAEON Biopharma announces exchange agreement with DaewoongDecember 16, 2025 | msn.comAEON Biopharma Announces Execution of Exchange Agreement with DaewoongDecember 15, 2025 | globenewswire.comAEON Biopharma (AEON) price target decreased by 15.28% to 6.22December 6, 2025 | msn.comMigraine Clinical Trial Pipeline Expands as 30+ Companies Driving Innovation in Oncology Therapeutics Space | DelveInsightDecember 2, 2025 | finance.yahoo.comAeon Biopharma announces rescheduling of BPD Type 2a meeting with FDANovember 21, 2025 | msn.comAEON Biopharma Announces First Closing of PIPE Investment and Provides Update on FDA Type 2a Meeting SchedulingNovember 20, 2025 | globenewswire.comAEON Biopharma Announces Fundraise Totaling Up to $22 Million through Private Placement and Proposed Exchange of Daewoong Convertible NotesNovember 14, 2025 | marketwatch.comAEON Biopharma Reports Third Quarter 2025 Results, Including Positive ABP-450 Biosimilarity Data and Strategic Positioning for Continued GrowthNovember 14, 2025 | globenewswire.comAEON Biopharma Reports Positive and Robust Biosimilarity Results: Identical Amino Acid Sequence and Highly Similar Functional Analysis DataNovember 13, 2025 | markets.businessinsider.comAEON Biopharma Announces Fundraise Totaling Up to ~$22 Million through Private Placement and Proposed Exchange of Daewoong Convertible NotesNovember 13, 2025 | globenewswire.comAeon Biopharma announces FDA BPD Type 2a meeting for ABP-450October 1, 2025 | msn.comAEON Biopharma Announces FDA BPD Type 2a Meeting for ABP-450 on November 19October 1, 2025 | globenewswire.comAEON Biopharma Releases Corporate PresentationSeptember 9, 2025 | msn.comAeon Biopharma Advances Biosimilar DevelopmentAugust 13, 2025 | msn.comAEON Biopharma Reports Second Quarter 2025 Financial Results and Provides Corporate UpdateAugust 12, 2025 | globenewswire.comAEON Biopharma, Inc. (AEON) - Yahoo FinanceJuly 11, 2025 | finance.yahoo.comHexagon launches AEON, a humanoid built for industryJune 17, 2025 | prnewswire.comAEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711May 23, 2025 | globenewswire.comJost Fischer Purchases 50,000 Shares of AEON Biopharma, Inc. (NASDAQ:AEON) StockMay 22, 2025 | insidertrades.comAEON Biopharma to Present Corporate Overview at Aegis Capital Corp. 2025 Virtual ConferenceMay 21, 2025 | nasdaq.comAEON Biopharma to Present at the Aegis Capital Corp. Virtual Conference 2025May 19, 2025 | globenewswire.comAEON Biopharma Reports First Quarter 2025 Financial Results and Provides Corporate UpdateMay 14, 2025 | globenewswire.comAEON Biopharma Announces NYSE American Acceptance of Plan to Regain Listing ComplianceApril 25, 2025 | globenewswire.comAEON Biopharma Announces Inducement Awards for New CEO Rob BancroftApril 23, 2025 | nasdaq.comAeon Biopharma appoints Rob Bancroft as CEOApril 21, 2025 | msn.comAEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711April 21, 2025 | globenewswire.comAEON Biopharma Appoints Industry Veteran Rob Bancroft as Chief Executive OfficerApril 21, 2025 | globenewswire.comBotulinum Toxin Market Forecast 2025-2030: Competitive Positioning, Strategies and Market Share AnalysisApril 14, 2025 | uk.finance.yahoo.comMineralys, Sana, Aeon: These 3 Biotech Stocks Saw The Sharpest Retail Interest Spike In Q1April 1, 2025 | msn.comAEON Biopharma announces leadership change amid growth strategyMarch 29, 2025 | investing.com Get AEON Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for AEON and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. AEON Media Mentions By Week AEON Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AEON News Sentiment▼0.000.39▲Average Medical News Sentiment AEON News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AEON Articles This Week▼10▲AEON Articles Average Week Get the Latest News and Ratings for AEON and Related Stocks Enter your email address to receive the latest news and analysts' ratings for AEON Biopharma and its competitors. Sign Up View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies FTLF News BTMD News ETHZ News ATRA News ACRV News GOSS News ANVS News CTOR News SPRB News GANX News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AEON) was last updated on 5/21/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredWhy this tiny stock may move before the SpaceX IPO dropsThe projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...Behind the Markets | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AEON Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AEON Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
